TEM Key Statistics, Chart & Performance
The current stock price of TEM is 61.2 USD. In the past month the price decreased by -18.79%. In the past year, price increased by 78.53%.
TEM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.05 | 219.22B | ||
| DHR | DANAHER CORP | 29.92 | 162.95B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 185.51 | 56.37B | ||
| A | AGILENT TECHNOLOGIES INC | 24.77 | 39.19B | ||
| IQV | IQVIA HOLDINGS INC | 19.53 | 38.69B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.87 | 28.95B | ||
| WAT | WATERS CORP | 30.34 | 22.94B | ||
| ILMN | ILLUMINA INC | 30.9 | 20.59B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.85 | 19.76B | ||
| MEDP | MEDPACE HOLDINGS INC | 39.97 | 16.10B | ||
| RVTY | REVVITY INC | 20.3 | 11.02B | ||
| CRL | CHARLES RIVER LABORATORIES | 19.23 | 9.99B |
Related stock screener links
About TEM
Company Profile
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 2,400 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Company Info
TEMPUS AI INC
600 West Chicago Avenue, Suite 510
Chicago ILLINOIS US
Employees: 2400
Phone: 18335144187
TEMPUS AI INC / TEM FAQ
What does TEM do?
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 2,400 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
What is the current price of TEM stock?
The current stock price of TEM is 61.2 USD. The price decreased by -2.39% in the last trading session.
Does TEM stock pay dividends?
TEM does not pay a dividend.
What is the ChartMill rating of TEMPUS AI INC stock?
TEM has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is TEMPUS AI INC (TEM) stock traded?
TEM stock is listed on the Nasdaq exchange.
Can you provide the sector and industry classification for TEMPUS AI INC?
TEMPUS AI INC (TEM) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Should I buy TEM stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TEM.
TEM Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to TEM. When comparing the yearly performance of all stocks, TEM is one of the better performing stocks in the market, outperforming 88.4% of all stocks.
TEM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TEM. TEM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
TEM Financial Highlights
Over the last trailing twelve months TEM reported a non-GAAP Earnings per Share(EPS) of -0.75. The EPS increased by 85.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.94% | ||
| ROE | -40.15% | ||
| Debt/Equity | 2.45 |
TEM Forecast & Estimates
19 analysts have analysed TEM and the average price target is 92.44 USD. This implies a price increase of 51.05% is expected in the next year compared to the current price of 61.2.
For the next year, analysts expect an EPS growth of 75.39% and a revenue growth 81.58% for TEM